Appleyard, Virginia C L <br/><br/>
Activity of MDI-301, a novel synthetic retinoid, in xenografts.  [electronic resource] 

 -  Anti-cancer drugs  Nov 2004 
 - 991-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200411000-00009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alitretinoin<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Nude<br/>Prostatic Neoplasms<br/>Receptors, Retinoic Acid--biosynthesis<br/>Retinoic Acid Receptor alpha<br/>Retinoids--pharmacology<br/>Tretinoin--pharmacology<br/>Xenograft Model Antitumor Assays